Related Experiment Videos
New advances in antifungal treatment
J L Finquelievich1, F C Odds, F Queiroz-Telles
1Mycology Center, School of Medicine, University of Buenos Aires and British Hospital of Buenos Aires, Argentina. ctromic@janssen.com.ar
Medical Mycology
|February 24, 2001
Summary
This review covers the clinical treatment of invasive aspergillosis, dematiaceous fungal infections, and endemic dimorphic fungal mycoses, offering insights into managing these serious conditions.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Medicine
Background:
- Invasive aspergillosis, dematiaceous fungal infections, and endemic dimorphic fungal mycoses pose significant clinical challenges.
- Effective treatment strategies are crucial for improving patient outcomes.
Purpose of the Study:
- To review the clinical aspects of treating invasive aspergillosis.
- To discuss the management of infections caused by dematiaceous fungi.
- To describe therapeutic approaches for mycoses caused by endemic, dimorphic fungi.
Main Methods:
- Literature review of clinical studies and case reports.
- Synthesis of current treatment guidelines and recommendations.
- Analysis of therapeutic options for specific fungal pathogens.
Main Results:
- Detailed description of treatment modalities for invasive aspergillosis, including antifungal agents and supportive care.
- Overview of diagnostic and therapeutic challenges in managing dematiaceous fungal infections.
- Discussion of the clinical spectrum and treatment of endemic mycoses caused by dimorphic fungi.
Conclusions:
- Optimizing treatment requires a thorough understanding of the specific fungal pathogen and host factors.
- Multidisciplinary approaches are often necessary for successful management.
- Continued research is needed to develop novel therapeutic strategies.